Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
ConclusionOverall, our findings suggest that bivalirudin may be a more efficacious intervention than heparin for reducing certain adverse events in patients with STEMI undergoing primary PCI.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Angiomax | Angioplasty | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Databases & Libraries | Heart | Heart Attack | Percutaneous Coronary Intervention | Stroke | Thrombosis